METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
Abstract
Cellular mRNA-protein (mRNP) complexes are partitioned in vivo by contacting a biological sample with at least one ligand that specifically binds at least one component of a mRNP complex. Suitable biological samples comprise at least one mRNA-protein (mRNP) complex and include cell cultures, cell extracts, and whole tissue, including tumor tissue. Ligands include antibodies that specifically bind RNA-binding or RNA-associated proteins present in the mRNP complex. The mRNP complex is separated by binding the ligand with a binding molecule specific for the ligand, where the binding molecule is attached to a solid support. The mRNP complex is collected by removing the mRNP complex from the solid support. After collecting the mRNP complex, the mRNA bound within the complex may be characterized and identified. Subsets of the total mRNA population of a cell may accordingly be characterized, and a gene expression profile of the cell obtained.
Claims
exact text as granted — not AI-modified1 . A method of characterizing RNA-protein complexes, the method comprising: a) expressing in a cell an epitope-tagged RNA-binding protein thereby forming an RNA-protein complexes, b) cross-linking the RNA-protein complexes; c) lysing the cell to produce a cell lysate; d) contacting the lysate with a ligand that specifically binds to the epitope tag; e) isolating the RNA-protein complexes from the lysate; and f) identifying RNAs en masse from the isolated RNA-protein complexes; wherein the nucleic acid encoding the epitope-tagged RNA-binding protein is under the control of a tissue-specific promoter.
Join the waitlist — get patent alerts
Track US2008254461A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.